China Healthcare Weekly (Dec.18)
The article analyzed the news about the negotiation result of PD-1/L1 in China VBP, industry viewpoints about radiotherapy and traditional Chinese...
429 Views
Simcere Pharmaceutical IPO: Valuation Insights
We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range
465 Views
Huge Short Covering Last Week
We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 20 March 2020.Total short...
364 Views
Hong Kong Buyback Weekly: Link Reit, Fosun Intl, Luye Pharma
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
298 Views
Alphamab Oncology IPO: Valuation Easy to Swallow
Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
521 Views